Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 42


Clinical biomarkers in sickle cell disease.

Damanhouri GA, Jarullah J, Marouf S, Hindawi SI, Mushtaq G, Kamal MA.

Saudi J Biol Sci. 2015 Jan;22(1):24-31. doi: 10.1016/j.sjbs.2014.09.005. Epub 2014 Sep 18. Review.


Vasculopathy and pulmonary hypertension in sickle cell disease.

Potoka KP, Gladwin MT.

Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L314-24. doi: 10.1152/ajplung.00252.2014. Epub 2014 Nov 14. Review.


Computed tomography correlates with cardiopulmonary hemodynamics in pulmonary hypertension in adults with sickle cell disease.

Linguraru MG, Pura JA, Gladwin MT, Koroulakis AI, Minniti C, Machado RF, Kato GJ, Wood BJ.

Pulm Circ. 2014 Jun;4(2):319-29. doi: 10.1086/675997.


Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom.

Gladwin MT, Barst RJ, Gibbs JS, Hildesheim M, Sachdev V, Nouraie M, Hassell KL, Little JA, Schraufnagel DE, Krishnamurti L, Novelli E, Girgis RE, Morris CR, Berman Rosenzweig E, Badesch DB, Lanzkron S, Castro OL, Taylor JG 6th, Goldsmith JC, Kato GJ, Gordeuk VR, Machado RF; walk-PHaSST Investigators and Patients.

PLoS One. 2014 Jul 2;9(7):e99489. doi: 10.1371/journal.pone.0099489. eCollection 2014.


An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Klings ES, Machado RF, Barst RJ, Morris CR, Mubarak KK, Gordeuk VR, Kato GJ, Ataga KI, Gibbs JS, Castro O, Rosenzweig EB, Sood N, Hsu L, Wilson KC, Telen MJ, Decastro LM, Krishnamurti L, Steinberg MH, Badesch DB, Gladwin MT; American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease.

Am J Respir Crit Care Med. 2014 Mar 15;189(6):727-40. doi: 10.1164/rccm.201401-0065ST.


Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia.

Cox SE, Soka D, Kirkham FJ, Newton CR, Prentice AM, Makani J, Younoszai AK.

Haematologica. 2014 Jan;99(1):e1-4. doi: 10.3324/haematol.2013.089235. No abstract available.


Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ, Campbell AD, Rana SR, Niu XM, Machado RF, Gladwin MT, Gordeuk VR.

Paediatr Respir Rev. 2014 Mar;15(1):4-12. doi: 10.1016/j.prrv.2013.11.003. Epub 2013 Nov 15. Review.


Pulmonary hypertension associated with chronic hemolytic anemia and other blood disorders.

Machado RF, Farber HW.

Clin Chest Med. 2013 Dec;34(4):739-52. doi: 10.1016/j.ccm.2013.08.006. Epub 2013 Oct 17. Review.


Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Nekhai S, Xu M, Foster A, Kasvosve I, Diaz S, Machado RF, Castro OL, Kato GJ, Taylor JG 6th, Gordeuk VR.

Haematologica. 2013 Mar;98(3):455-63. doi: 10.3324/haematol.2012.066530. Epub 2012 Oct 12.


Cardiovascular abnormalities in sickle cell disease.

Gladwin MT, Sachdev V.

J Am Coll Cardiol. 2012 Mar 27;59(13):1123-33. doi: 10.1016/j.jacc.2011.10.900. Review.


Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis.

Deonikar P, Kavdia M.

J Appl Physiol (1985). 2012 Apr;112(8):1383-92. doi: 10.1152/japplphysiol.01173.2011. Epub 2012 Jan 5.


Correlation of N-terminal fragment of B-type natriuretic peptide levels with clinical, laboratory, and echocardiographic abnormalities in children with sickle cell disease.

Takatsuki S, Ivy DD, Nuss R.

J Pediatr. 2012 Mar;160(3):428-433.e1. doi: 10.1016/j.jpeds.2011.09.015. Epub 2011 Nov 1. Erratum in: J Pediatr. 2012 Mar;160(3):533.


NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.

Machado RF, Hildesheim M, Mendelsohn L, Remaley AT, Kato GJ, Gladwin MT.

Br J Haematol. 2011 Aug;154(4):512-20. doi: 10.1111/j.1365-2141.2011.08777.x. Epub 2011 Jun 21.


Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.

Minniti CP, Wilson J, Mendelsohn L, Rigdon GC, Stocker JW, Remaley AT, Kato GJ.

Br J Haematol. 2011 Dec;155(5):634-6. doi: 10.1111/j.1365-2141.2011.08757.x. Epub 2011 Jun 8. No abstract available.


Pulmonary hypertension in hemolytic anemias.

Wahl S, Vichinsky E.

F1000 Med Rep. 2010 Feb 11;2. pii: 10. doi: 10.3410/M2-10.


Pulmonary hypertension and NO in sickle cell.

Gladwin MT, Barst RJ, Castro OL, Gordeuk VR, Hillery CA, Kato GJ, Kim-Shapiro DB, Machado R, Morris CR, Steinberg MH, Vichinsky EP.

Blood. 2010 Aug 5;116(5):852-4. doi: 10.1182/blood-2010-04-282095. No abstract available.


Increased pulmonary pressures and myocardial wall stress in children with severe malaria.

Janka JJ, Koita OA, Traoré B, Traoré JM, Mzayek F, Sachdev V, Wang X, Sanogo K, Sangaré L, Mendelsohn L, Masur H, Kato GJ, Gladwin MT, Krogstad DJ.

J Infect Dis. 2010 Sep 1;202(5):791-800. doi: 10.1086/655225.


Pulmonary hypertension in hemolytic disorders: pulmonary vascular disease: the global perspective.

Machado RF, Gladwin MT.

Chest. 2010 Jun;137(6 Suppl):30S-38S. doi: 10.1378/chest.09-3057.


The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Steinberg MH, McCarthy WF, Castro O, Ballas SK, Armstrong FD, Smith W, Ataga K, Swerdlow P, Kutlar A, DeCastro L, Waclawiw MA; Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia and MSH Patients' Follow-Up.

Am J Hematol. 2010 Jun;85(6):403-8. doi: 10.1002/ajh.21699.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk